Effect of Exercise Training on Left Ventricular Function in Patients Post Myocardial Infarction
NCT ID: NCT02048696
Last Updated: 2018-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2014-02-28
2018-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periodization of Exercise Training in Patients With Coronary Heart Disease.
NCT03443193
Aerobic Interval Training in Cardiac Rehabilitation
NCT00964067
Individualized Exercise Training Based on the Heart Rate Variability in Coronary Heart Disease Patient
NCT04971707
High-intensity Interval Training in Patients With Post-acute Coronary Syndrome
NCT03414996
Effect Evaluation of Early Exercise Training After Myocardial Infarction
NCT00246545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is known that exercise training preserves heart function in patients who have suffered a myocardial infarction. The mechanism for this is not clear.
The purpose of this study is to examine the effect of exercise training on myocardial function and GRK2 levels in patients who have suffered a myocardial infarction, with the hypothesis that exercise training in this population reduces GRK2 levels and preserves or improves myocardial function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise training
Secondary prevention and cardiac rehabilitation clinic of the Montreal Heart Institute. Subjects will undergo twice weekly exercise training with high intensity interval training for a period of 12 weeks.
Secondary prevention and cardiac rehabilitation clinic
Secondary prevention and cardiac rehabilitation clinic of the Montreal Heart Institute. Subjects will undergo twice weekly exercise training with high intensity interval training for a period of 12 weeks.
control
Individuals in this group are offered current ACC/AHA recommendations on physical activity in patients post-myocardial infarction.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Secondary prevention and cardiac rehabilitation clinic
Secondary prevention and cardiac rehabilitation clinic of the Montreal Heart Institute. Subjects will undergo twice weekly exercise training with high intensity interval training for a period of 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Complete revascularization: no residual major epicardial coronary artery coronary stenosis ≥ 70%; no residual left main coronary stenosis ≥ 40%.
* Stage A-C heart failure, New York Heart Association class I-III.
* Stable dose of medications during the 4 weeks prior to enrolment.
* Able to perform a maximal cardiopulmonary stress test.
* Capacity and willingness to provide sign informed consent.
Exclusion Criteria
* Coronary artery bypass surgery: patients post coronary artery bypass graft exhibit wall motion abnormalities that may interfere with speckle tracking analysis.
* Incomplete revascularization with major epicardial coronary artery (left anterior descending, circumflex, or right coronary) stenosis ≥ 70%.
* Myocardial necrosis in the absence of significant flow limiting coronary artery stenosis or thrombosis, with the exception of documented STEMI and successful thrombolytic therapy resulting on no significant residual epicardial coronary artery stenosis.
* Significant valvular disease that is greater than moderate in severity
* History of non-ischemic cardiomyopathy (dilated, restrictive, infiltrative cardiomyopathy, hypertrophic, LV non compaction, or Takotsubo cardiomyopathy)
* Significant resting ECG abnormalities that preclude accurate speckle tracking.
* Paced rhythm.
* left bundle branch block
* Atrial arrhythmias (ex. persistent/permanent atrial fibrillation, atrial flutter).
* Frequent ventricular ectopics
* Significant ventricular arrhythmias (non-sustained ventricular tachycardia or syncope).
* New York Heart Association class IIIb - IV symptoms.
* Severe LV systolic dysfunction (Ejection fraction ≤ 30%)
* Active decompensated heart failure with orthopnea or paroxysmal nocturnal dyspnea.
* Uncontrolled resting arterial hypertension \> 180/110 mmHg.
* More than moderate systemic disease
* Chronic inflammation or infection.
* Any contraindication to exercise training or any condition limiting ability to partake in adequate exercise stress testing or training (peripheral artery disease, articular, neurologic, or psychiatric pathology)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montreal Heart Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anil Nigam, MD
Role: PRINCIPAL_INVESTIGATOR
Montreal Heart Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for preventive medicine and physical activity of the Montreal Heart Institute (Centre ÉPIC)
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Trachsel LD, Boidin M, Henri C, Fortier A, Lalonge J, Juneau M, Nigam A, Gayda M. Women and men with coronary heart disease respond similarly to different aerobic exercise training modalities: a pooled analysis of prospective randomized trials. Appl Physiol Nutr Metab. 2021 May;46(5):417-425. doi: 10.1139/apnm-2020-0650. Epub 2020 Oct 23.
Trachsel LD, Nigam A, Fortier A, Lalonge J, Juneau M, Gayda M. Moderate-intensity continuous exercise is superior to high-intensity interval training in the proportion of VO2peak responders after ACS. Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):725-733. doi: 10.1016/j.rec.2019.09.013. Epub 2019 Dec 16. English, Spanish.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-1509
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.